These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3667544)

  • 1. High-dosage tranylcypromine in refractory depression.
    Pearlman C
    J Clin Psychiatry; 1987 Oct; 48(10):424-5. PubMed ID: 3667544
    [No Abstract]   [Full Text] [Related]  

  • 2. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranylcypromine addiction: a case report and review.
    Briggs NC; Jefferson JW; Koenecke FH
    J Clin Psychiatry; 1990 Oct; 51(10):426-9. PubMed ID: 2211541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of tranylcypromine-induced hallucination].
    Hoffmann W
    Psychiatr Prax; 1993 May; 20(3):116. PubMed ID: 8378483
    [No Abstract]   [Full Text] [Related]  

  • 6. Amphetamine and tranylcypromine in treatment-resistant depression.
    Sovner R
    Biol Psychiatry; 1990 Dec; 28(11):1011-2. PubMed ID: 2275949
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia and delirium associated with tranylcypromine overdose.
    Chatterjee A; Tosyali MC
    J Clin Psychopharmacol; 1995 Apr; 15(2):143-4. PubMed ID: 7782490
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of major depression: acute effect of withdrawing antidepressants.
    Halle MH; Del Medico VJ; Dilsaver SC
    Acta Psychiatr Scand; 1991 Mar; 83(3):238-9. PubMed ID: 2031468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinduction of hypertensive reactions by tranylcypromine.
    da Motta T; Cordás TA
    J Clin Psychopharmacol; 1990 Jun; 10(3):232. PubMed ID: 2376623
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the effectiveness of tranylcypromine, nortriptyline, thioridazine and amitriptyline in two syndromological types of endogenous depression (author's transl)].
    Náhunek K; Svestka J; Cesková E; Rysánek R; Novotná H
    Cesk Psychiatr; 1981; 77(4):245-52. PubMed ID: 7318002
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of molindone and tranylcypromine in the treatment of refractory depression.
    Small JG; Kellams JJ; Dennis JL; Milstein V
    J Clin Pharmacol; 1981; 21(8-9):351-8. PubMed ID: 7276229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence on monoamine oxidase inhibitors in high dose.
    Vartzopoulos D; Krull F
    Br J Psychiatry; 1991 Jun; 158():856-7. PubMed ID: 1873639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of acquired Tourettism and major depression.
    Malone DA; Stern TA
    J Geriatr Psychiatry Neurol; 1988; 1(3):169-71. PubMed ID: 3252884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.